Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1968-6-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0003-3022
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
471-7
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:5647496-Acetazolamide,
pubmed-meshheading:5647496-Animals,
pubmed-meshheading:5647496-Cerebrovascular Circulation,
pubmed-meshheading:5647496-Dogs,
pubmed-meshheading:5647496-Hypercapnia,
pubmed-meshheading:5647496-Hypoxia, Brain,
pubmed-meshheading:5647496-Injections, Intravenous,
pubmed-meshheading:5647496-Oxygen Consumption
|
pubmed:articleTitle |
The effects of acetazolamide on cerebral blood flow and cerebral tissue PO2.
|
pubmed:publicationType |
Journal Article
|